Scientific Literature Search

Open access

Structural Alterations in the Gray Matter Volume in Rapid-Onset Dystonia-Parkinsonism.

Haq IU, Simonyan K, Napoli E, Ozelius LJ, Snively BM, Whitlow CT, Sweadner KJ, Brashear A.

Mov Disord · 2025-09-01

DOI: 10.1002/mds.30320PMID: 40888012

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Navigating the Neuropsychiatric Risks of Foslevodopa/Foscarbidopa in Patients with Parkinson's Disease.

Solla P, Velucci V, Defazio G, Ercoli T.

Mov Disord Clin Pract · 2025-09-01

DOI: 10.1002/mdc3.70324PMID: 40888252

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Reply: "Navigating the Neuropsychiatric Risks of Foslevodopa/Foscarbidopa in Patients with Parkinson's Disease".

Hauw F, Méneret A, Mantisi L, Letrillart H, Grabli D, Brohée S, Roze E.

Mov Disord Clin Pract · 2025-09-01

DOI: 10.1002/mdc3.70331PMID: 40888278

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Remote ischemic conditioning as a potential therapy for Parkinson's Disease: Inhibiting TLR4-Driven neuroinflammation and oxidative damage.

Cai L, Ding Y, Tekreeti AA, Li F, Zhu Y, Geng X, Ji X.

Brain Res · 2025-09-01

DOI: 10.1016/j.brainres.2025.149920PMID: 40902700

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Associations of ambient particulate matter and nitrogen dioxide with hospital admissions for Parkinson's disease: A nationwide case-crossover study in China.

Bai L, Jiang Y, Zhang K, Su H, Sun S, Deng F, Baccarelli AA, Shi X, Guo X, Wu S.

Environ Pollut · 2025-09-01

DOI: 10.1016/j.envpol.2025.127062PMID: 40902708

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Epidemiology of autonomic dysfunction in Parkinson's disease (Review).

Rissardo JP, Gadelmawla AF, Khalil I, Abdulgadir A, Bhatti KS, Fornari Caprara AL.

Med Int (Lond) · 2025-09-01

DOI: 10.3892/mi.2025.267PMID: 41018272

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Parkinson's disease incidence in glaucoma patients from israel: insights from a 20-year follow-up sample.

Kozlov Y, Geffen N, Shulman S, Zahavi A, Gal-Or O, Dotan A, Gazit S, Patalon T, Meshi A.

Graefes Arch Clin Exp Ophthalmol · 2025-09-01

DOI: 10.1007/s00417-025-06953-zPMID: 40888892

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

CSF Mitochondrial DNA: Biomarker of Body Composition and Energy Metabolism in Parkinson's Disease.

Mizutani Y, Nakai T, Maeda Y, Ohdake R, Higashi A, Maeda T, Nagao R, Shima S, Kawabata K, Ueda A, Ito M, Watanabe H.

Ann Clin Transl Neurol · 2025-09-01

DOI: 10.1002/acn3.70183PMID: 40891077

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized Trial.

Schiess MC, Suescun J, Martinez-Lemus JD, Green C, Thomas TS, Shahnawaz M, Tharp E, Satani NB, Saltarrelli JG, Adams C, Doursout MF, Thyne V, Abuamouneh R, Rodarte EM, Savitz SI, Ellmore TM.

Mov Disord · 2025-09-01

DOI: 10.1002/mds.70028PMID: 40891094

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Midlife Physical Activity, Disease Symptoms, and Quality of Life in Parkinson's Disease: A Structural Equation Modeling Approach.

DeMarco E, Lindish J, Held-Bradford E, Longhurst JK.

J Phys Act Health · 2025-09-01

DOI: 10.1123/jpah.2024-0583PMID: 40897345

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Validation of the French Translation of the Movement Disorder Society Non-Motor Symptoms Scale (MDS-NMS) in Parkinson's Disease.

Desjardins C, Grimaldi S, Luo S, Yu L, Goetz CG, Stebbins GT, Martinez-Martin P, Kurtis MM, Mestre TA, Sanchez-Ferro A, Tosin MHS, Balestrino R, Lin CR, Gasca-Salas C, Witjas T, Colin O, Maltete D, Defebvre L, Giordana C, Charif M, Thiriez C, Laurencin C, Tir M, Dupont G, Remy P, Tranchant C, Drapier S, Samier A, Benatru I, Sambin S, Corvol JC, Khelifi F, Fabbri M, Rascol O, NS‐Part Cohort study group and the MDS COA Translation Steering Committee.

Mov Disord Clin Pract · 2025-09-01

DOI: 10.1002/mdc3.70323PMID: 40888151

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Early Onset Dystonia, Parkinsonism, and Spasticity in Siblings with VAC14-Associated Neurodegeneration: A Case Report and Literature Review.

Lindsay R, Yoganathan S, Lim WK, Krishnan P, Doja A, Venkateswaran S, Richer J, Breitbart S, Liang NSY, Fasano A, Ibrahim GM, Gorodetsky C.

Mov Disord Clin Pract · 2025-09-01

DOI: 10.1002/mdc3.70335PMID: 40888261

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

106.816 articles found

Structural Alterations in the Gray Matter Volume in Rapid-Onset Dystonia-Parkinsonism.

Navigating the Neuropsychiatric Risks of Foslevodopa/Foscarbidopa in Patients with Parkinson's Disease.

Reply: "Navigating the Neuropsychiatric Risks of Foslevodopa/Foscarbidopa in Patients with Parkinson's Disease".

Remote ischemic conditioning as a potential therapy for Parkinson's Disease: Inhibiting TLR4-Driven neuroinflammation and oxidative damage.

Associations of ambient particulate matter and nitrogen dioxide with hospital admissions for Parkinson's disease: A nationwide case-crossover study in China.

Epidemiology of autonomic dysfunction in Parkinson's disease (Review).

Parkinson's disease incidence in glaucoma patients from israel: insights from a 20-year follow-up sample.

CSF Mitochondrial DNA: Biomarker of Body Composition and Energy Metabolism in Parkinson's Disease.

Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized Trial.

Midlife Physical Activity, Disease Symptoms, and Quality of Life in Parkinson's Disease: A Structural Equation Modeling Approach.

Validation of the French Translation of the Movement Disorder Society Non-Motor Symptoms Scale (MDS-NMS) in Parkinson's Disease.

Early Onset Dystonia, Parkinsonism, and Spasticity in Siblings with VAC14-Associated Neurodegeneration: A Case Report and Literature Review.

Filters